Pruritus in cutaneous T-cell lymphomas: frequent, often severe and difficult to treat

Acta Derm Venereol. 2010;90(1):12-7. doi: 10.2340/00015555-0789.

Abstract

Pruritus has a well-known association with Hodgkin's disease and other nodal lymphomas; indeed it often reveals the disease. Pruritus is also an important symptom of cutaneous T-cell lymphomas. Lymphoma-associated itch is thus both frequent and severe, but its pathophysiology remains unclear. Few studies have evaluated the efficacy of therapeutic agents in the management of cutaneous T-cell lymphoma-related pruritus. The main objective of treatment remains disease control. Pruritus management is generally based on the physician's experience. Treatment is very difficult, especially in Sézary syndrome. We present here management strategies for cutaneous lymphoma-associated pruritus.

Publication types

  • Review

MeSH terms

  • Antipruritics / therapeutic use*
  • Humans
  • Lymphoma, T-Cell, Cutaneous / complications*
  • Lymphoma, T-Cell, Cutaneous / therapy
  • Phototherapy
  • Pruritus / diagnosis
  • Pruritus / drug therapy*
  • Pruritus / etiology
  • Pruritus / physiopathology
  • Severity of Illness Index
  • Sezary Syndrome / complications*
  • Sezary Syndrome / therapy
  • Skin Neoplasms / complications*
  • Skin Neoplasms / therapy
  • Treatment Outcome

Substances

  • Antipruritics